Pulmonary fibrosis (IPF)
Would you like to receive a message when there is new research on Idiopathic Pulmonary Fibrosis (IPF)? This is possible with an account. Create a free account or log in.
EU designated: ERN-LUNG
For pulmonary fibrosis (ipf) there is a European Reference Network for rare lung diseases. These are hospitals that have been approved after a European assessment designated as an expertise centre — a recognition, not a count by us.
If you want to go to such a center, it goes through a referral from your own specialist. We do not arrange that and cannot have a say in it.
Centres of Expertise Worldwide
For pulmonary fibrosis (ipf) we have 60 centers in view in 11 countries, of which 58 currently recruiting participants.
Which hospitals these are is part of Premium. You can then see per center how many studies on pulmonary fibrosis (ipf) are running or have run, in which city and country it is located, and whether participants are currently being recruited — with a link to the official registry.
Everything known about pulmonary fibrosis (ipf) — the explanation, the symptoms, the treatment methods and all publications and studies — remains free to read. This overview is not a referral and not a judgment on care; always discuss a referral with your own specialist.
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.